Approximately 30% of clinical trials fail due to safety and toxicity concerns, highlighting the ongoing challenge of delivering effective therapies without causing harmful off-target effects. Despite significant progress in drug development, most current delivery methods still depend on systemic administration, which naturally exposes healthy tissues and narrows the therapeutic window.

‍

Panelist

Traditional manufacturing methods can't scale AI-native therapeutics.
With AI entering the R&D space, discovery is now exponential; while manufacturing remains linear, rigid and extraordinarily slow.
Digital R&D can cut timelines by 30–50%. But tech transfer still takes years. Production still relies on manual documentation. Scale up still depends on trial and error. A delayed launch can cost more than a million dollars every single day.
We’ve arrived at an inflection point: Exponential technologies have collided with linear systems.

‍

The care crisis is real: Over 5.7 million people in Germany require long-term care, and 86% are cared for at home. Family caregivers are the backbone of the system, often overwhelmed and at their limits.
Nui Care has been on the market for several years with a proven track record and is now scaling its AI-driven platform to reach even more family caregivers. Led by Co-founder and CEO Markus C. Müller, an experienced entrepreneur with a history of building innovative digital solutions, Nui provides the next generation of digital care support that empowers, connects, and relieves family caregivers. The Nui app serves as a central digital care companion, offering clear, easy-to-understand answers to all care-related questions, helping families optimize their care budget, completing care applications in minutes, and providing direct access to professional care experts, community support, and practical guidance.

‍

‍

Faciliator

Faciliator

Panelist

For decades, breastfeeding has been one of the most vital yet least quantified aspects of human health. Mothers have been forced to rely on "best guesses" while researchers faced a global data void regarding what a "normal" supply actually looks like. Coroflo is changing that. By merging medical-grade technology with everyday usability, Coroflo is moving beyond guesswork to provide mothers with the accurate, real-time information they need to reach their feeding goals. This presentation explores how Coroflo’s patented flow-measurement technology is not only empowering individual journeys but is also fueling global research groups to finally establish a foundational baseline for breastfeeding science.

‍

The idea of a “sentient” machine sounds strange to many of us, but it is already on the threshold of our everyday lives. Can emotions such as compassion or joy even be algorithmized? What happens when machines are able not only to recognize human emotions, but also to respond to them empathetically?

‍

QuantumAI in Life Science

‍

Moderator

The healthcare sector is undergoing a fundamental transformation driven by digitalization, workforce challenges, and rising expectations for more efficient, patient‑centered care. Building the Smart Hospital of the future requires more than technology—it demands strong, trust‑based collaboration between clinical partners, industry, and innovative startups. In this joint presentation, Siemens and Kantonsspital Baden (KSB) showcase how such a collaborative ecosystem accelerates real‑world innovation.

‍

Moderator

Moderator

TBA

A fast‑paced conversation with founders, investors, and shapers on what’s really working in digital diagnostics, AI‑enabled care, and techbio—and what isn’t. Spotlight on POWHER Award winners translating bold ideas into measurable patient and system impact.

‍

Panelist

Panelist

Facilitator

‍

Facilitator

‍

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

The promise of AI in healthcare hinges on a digital backbone that transforms hospitals from data silos into intelligent ecosystems. This session brings together leaders to discuss the operational blueprints and financial strategies essential for Switzerland’s AI-ready future. Join us alongside global leaders and featured speakers to explore the investments required to turn clinical data into life-saving intelligence.

‍

Implementing "Lab-in-the-Loop" for drug discovery faces scientific, engineering, and cultural hurdles, requiring a seamless 'bits and atoms' integration. Panelists will debate the maturity of closed-loop discovery, unpacking real-world lessons, bottlenecks in automation and data, and charting a path for adoption.

‍

The promise of AI in healthcare hinges on a digital backbone that transforms hospitals from data silos into intelligent ecosystems. This session brings together leaders to discuss the operational blueprints and financial strategies essential for Switzerland’s AI-ready future. Join us alongside global leaders and featured speakers to explore the investments required to turn clinical data into life-saving intelligence.

‍

Hospitals run countless innovation pilots, yet very few ever scale. The barrier is rarely the technology—it’s procurement, governance, and risk management. This session brings together hospital leaders, an innovation procurement expert, and a startup to explore how innovation procurement tools can bridge the gap between piloting and buying. Attendees will gain practical insights into creating smarter pathways for real, scalable adoption of digital health solutions.

‍

Clinical trials are a critical constraint in global drug development, consuming over half of total R&D costs and stretching timelines by years. The tools to change this already exist. AI-powered design, digital recruitment, and decentralised trial platforms have proven they can shorten timelines, expand inclusion, and improve success rates. Unlocking faster, smarter, and more inclusive trials will require targeted investment, regulatory alignment, and bold collaboration between pharma, investors, and digital innovators.

‍

This session will explore participatory approaches in assistive robotics across research, education, technology transfer, and dialogue with society, including initiatives such as the Medical Engineering course in the Bachelor of Human Medicine at ETH Zurich and the CYBATHLON. The presentation is jointly delivered by Professor Roger Gassert, who directs the Rehabilitation Engineering Laboratory at ETH Zurich, and Werner Witschi, an experienced speaker and a paraplegic. We will highlight how we engage with individuals with disabilities actively to develop technology at every step of the process, and how the teaching curriculum involves them early on to ensure students are exposed to the realities of living with a disability. We will discuss associated challenges and draw on first-hand experience from various projects, including the development of, training with, and research on a lower-limb exoskeleton that participated in the CYBATHLON 2016.

‍

Panelist

In an era of exponential scientific output, researchers face a mounting challenge: the “Breadth-Depth Dilemma.” Staying current with global literature across intersecting disciplines while maintaining deep, niche expertise has become a human impossibility. Because major breakthroughs increasingly occur at the crossroads of fields - such as microbiology and genetics for example - the cognitive load required to bridge these domains has become a critical bottleneck in R&D.

‍

Keepc-AI-ring: Futureproofing Health and Care Systems Safeguarding Health Care Workers in Hospital SettingsHealthcare systems are under growing strain as workforce shortages, burnout, and psychological stress impair quality of care and patient safety. This keynote presents KEEPCARING, a Horizon Europe-funded initiative focused on strengthening the well-being and resilience of surgical teams through responsible, human-centred technology.

‍

Digital endpoints—from wearable sensors and mobile apps to connected home devices—are transforming how we measure outcomes in clinical trials, offering higher-frequency, real-world, and patient-centered data. Translating these novel measures into reliable, regulatory-acceptable endpoints requires an integrated approach spanning scientific rationale, device and algorithm qualification, data integrity, patient engagement, and operational execution. The presentation and panel will provide pragmatic, actionable guidance for designing, validating, and delivering digital endpoints in clinical trials, drawing on real-world examples and lessons learned.

‍

The EU's Data Act and AI Act are reshaping digital health regulation. This masterclass will explore the practical implications of these frameworks, examining where compliance introduces friction versus strategic opportunities. Learn what healthcare organizations should do now to prepare for data access, interoperability, and trustworthy AI.

‍

Guest

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

Stage Host

In the rapidly evolving health tech landscape, transitioning from a startup to a scaleup is a pivotal moment filled with both exhilarating opportunities and formidable challenges. This masterclass gathers seasoned founders who have successfully navigated this journey, sharing invaluable insights and lessons learned along the way. Participants will explore key strategies for scaling operations, securing funding, and building resilient teams. Real-world case studies will highlight adaptive leadership, innovation, and market positioning, providing actionable takeaways for entrepreneurs at all stages. Join us to unlock the secrets of scaling health tech ventures and to gain perspective from those who have turned ambitious visions into thriving realities.

‍

This session presents the necessary shift in healthcare, from one-size-fits-all approaches to personalized, risk-based medicine. We are entering an era where diseases can be predicted years before symptoms appear, enabling early action and often prevention. This transformation affects the entire care ecosystem: health organizations can allocate resources more effectively, clinicians can focus on maintaining health rather than just treating illness, and patients can take an active role in their own care. The goal is genuine healthcare, anticipating and reducing risk before disease develops.

‍

Access to affordable medicines is one of the most pressing challenges facing healthcare systems today. Rising costs, demographic change, fragile supply chains, and growing system pressures are placing significant strain on patients, payers, and providers, while the need for innovation in life saving and essential medicines continues to grow.

‍

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

Implementing "Lab-in-the-Loop" for drug discovery faces scientific, engineering, and cultural hurdles, requiring a seamless 'bits and atoms' integration. Panelists will debate the maturity of closed-loop discovery, unpacking real-world lessons, bottlenecks in automation and data, and charting a path for adoption.

‍

‍

Our healthcare system is fundamentally broken — it reacts instead of preventing. We run tests, wait for lab results, and start treatment once the disease has already progressed. This reactive model leaves patients and doctors constantly one step behind. But what if we could act before illness takes hold? What if our bodies could tell us when something is going wrong — and we actually listened?

‍

Benefit–risk assessment (BRA) sits at the core of drug development, regulatory decision-making, and pharmacovigilance. Yet today, BRA remains largely retrospective and fragmented, relying on static analyses of heterogeneous evidence that struggle to capture causality, uncertainty, and the dynamic nature of clinical outcomes. This talk introduces a new paradigm: Medical World Models as a foundational layer for next-generation benefit–risk assessment.

‍

The promise of AI in healthcare hinges on a digital backbone that transforms hospitals from data silos into intelligent ecosystems. This session brings together leaders to discuss the operational blueprints and financial strategies essential for Switzerland’s AI-ready future. Join us alongside global leaders and featured speakers to explore the investments required to turn clinical data into life-saving intelligence.

‍

The promise of AI in healthcare hinges on a digital backbone that transforms hospitals from data silos into intelligent ecosystems. This session brings together leaders to discuss the operational blueprints and financial strategies essential for Switzerland’s AI-ready future. Join us alongside global leaders and featured speakers to explore the investments required to turn clinical data into life-saving intelligence.

‍

The EU's Data Act and AI Act are reshaping digital health regulation. This masterclass will explore the practical implications of these frameworks, examining where compliance introduces friction versus strategic opportunities. Learn what healthcare organizations should do now to prepare for data access, interoperability, and trustworthy AI.

‍

In vitro fertilization is one of the most technologically advanced areas of medicine, yet for healthcare professionals delivering IVF care, everyday work can feel outdated. Fragmented systems, manual coordination, duplicated documentation, and constant interruptions create operational friction that slows decisions, increases cognitive load, and pulls clinicians away from patients.

‍

As technology advances, the use of consumer health data in personal wellness practices raises important questions about our relationship with health. This panel examines the dual nature of health technology: while it empowers informed decision-making and proactive health management, it can also foster an obsession with metrics that may affect mental well-being. Experts will discuss the implications of quantified self-movements, data privacy, and the psychological effects of constant monitoring.  Learn to balance the benefits of health data with the risks of overemphasis on achievement, striving for a healthier, more holistic approach to personal care. Join us as we explore whether our pursuit of health enhances well-being or simply fuels fixation on data.

‍

A multidisciplinary masterclass exploring UX as a clinical, emotional, and systemic success factor, showing how human-centered design, clinician psychology, and engagement frameworks drive adoption, safety, and sustainable impact in digital healthcare.

‍

Algorithms are already shaping some clinical decisions, from diagnostics to risk stratification. But what if, in the future, algorithms went further, for example, deciding treatment plans and prescriptions themselves?

‍

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

Access to affordable medicines is one of the most pressing challenges facing healthcare systems today. Rising costs, demographic change, fragile supply chains, and growing system pressures are placing significant strain on patients, payers, and providers, while the need for innovation in life saving and essential medicines continues to grow.

‍

Hospitals run countless innovation pilots, yet very few ever scale. The barrier is rarely the technology—it’s procurement, governance, and risk management. This session brings together hospital leaders, an innovation procurement expert, and a startup to explore how innovation procurement tools can bridge the gap between piloting and buying. Attendees will gain practical insights into creating smarter pathways for real, scalable adoption of digital health solutions.

‍

Hospitals run countless innovation pilots, yet very few ever scale. The barrier is rarely the technology—it’s procurement, governance, and risk management. This session brings together hospital leaders, an innovation procurement expert, and a startup to explore how innovation procurement tools can bridge the gap between piloting and buying. Attendees will gain practical insights into creating smarter pathways for real, scalable adoption of digital health solutions.

‍

Hospitals run countless innovation pilots, yet very few ever scale. The barrier is rarely the technology—it’s procurement, governance, and risk management. This session brings together hospital leaders, an innovation procurement expert, and a startup to explore how innovation procurement tools can bridge the gap between piloting and buying. Attendees will gain practical insights into creating smarter pathways for real, scalable adoption of digital health solutions.

‍

Faces of Digital Health Podcast - Ask the Expert

‍

Impulse Podcast - Fireside Chat

‍

In an era of ecological dysregulation, the traditional biomedical model—focused on individual pathology—is insufficient. This presentation introduces Planetary Salutogenesis, a paradigm shift that scales health promotion from the individual to the biosphere. Currently being actively developed at Charité Berlin, Planetary Salutogenesis posits that durable human health is contingent upon a healthy planet. The framework moves beyond "sick care" to actively cultivate a "Sense of Coherence" by treating the planetary environment as a primary determinant of individual vitality. By integrating traditional medical wisdom with high-tech research, Planetary Salutogenesis addresses systemic health needs through preventative and restorative practices, often drawn from a vast compendium of traditional, complementary and integrative medical practices. This presentation will outline the intellectual framework for Planetary Salutogenesis, bridging health care economics and planetary governance to move medicine toward a proactive, "all-of-planet" view that fosters resilience for humans and non-humans alike.

‍

Most strategic transactions don’t fail at signing. They fail at execution.

Acquisitions, partnerships, and exits often look flawless on paper — yet value erodes once governance shifts, incentives misalign, and decision-making slows down. These risks are usually visible before the deal is signed, but rarely addressed openly.

This roundtable brings together startup CEOs nearing a strategic transaction and experienced M&A professionals from pharma, diagnostics, and digital health to have an honest, execution-first conversation.

We will examine where deals actually break, what founders tend to underestimate about power and control shifts, and what acquirers already know will be hard to execute — but sign anyway.
We will have a candid exchange on how to prevent value destruction between signing and integration.

Hosted by Valérie Hepp, founder of Breakline Resolution, specialising in execution risk, high-stakes negotiation, and conflict resolution in strategic life-sciences transactions.

‍

A multidisciplinary masterclass exploring UX as a clinical, emotional, and systemic success factor, showing how human-centered design, clinician psychology, and engagement frameworks drive adoption, safety, and sustainable impact in digital healthcare.

‍

This masterclass will explore how clinical decision-making algorithms are applied in real-world healthcare settings. Experts from leading organizations in Germany will share first-hand experiences on implementing, and using algorithms to support clinical decisions, highlighting both impact and practical challenges.

‍

In the rapidly evolving health tech landscape, transitioning from a startup to a scaleup is a pivotal moment filled with both exhilarating opportunities and formidable challenges. This masterclass gathers seasoned founders who have successfully navigated this journey, sharing invaluable insights and lessons learned along the way. Participants will explore key strategies for scaling operations, securing funding, and building resilient teams. Real-world case studies will highlight adaptive leadership, innovation, and market positioning, providing actionable takeaways for entrepreneurs at all stages. Join us to unlock the secrets of scaling health tech ventures and to gain perspective from those who have turned ambitious visions into thriving realities.

‍

Facilitator

‍

Facilitator

‍

In an era of ecological dysregulation, the traditional biomedical model—focused on individual pathology—is insufficient. This presentation introduces Planetary Salutogenesis, a paradigm shift that scales health promotion from the individual to the biosphere. Currently being actively developed at Charité Berlin, Planetary Salutogenesis posits that durable human health is contingent upon a healthy planet. The framework moves beyond "sick care" to actively cultivate a "Sense of Coherence" by treating the planetary environment as a primary determinant of individual vitality. By integrating traditional medical wisdom with high-tech research, Planetary Salutogenesis addresses systemic health needs through preventative and restorative practices, often drawn from a vast compendium of traditional, complementary and integrative medical practices. This presentation will outline the intellectual framework for Planetary Salutogenesis, bridging health care economics and planetary governance to move medicine toward a proactive, "all-of-planet" view that fosters resilience for humans and non-humans alike.

‍

Moderator

Panelist

Moderator

In an era where technology reshapes healthcare delivery, this panel brings together innovation leads from the world's most future-focused hospitals. These experts will share their insights on designing digital infrastructures that prioritize patient care while addressing societal health needs. Topics will include leveraging data analytics for personalized medicine, implementing telehealth solutions to enhance accessibility, and creating collaborative ecosystems that engage patients in their own care. Attendees will gain a deeper understanding of how to integrate cutting-edge technologies with human-centric approaches, fostering hospitals that not only heal but also enrich the communities they serve. Join us for an engaging discussion on the transformative power of digital design in healthcare.

‍

For years, the narrative of Artificial Intelligence has been one of replacement. But in the front lines of high-stakes research and innovation, a more profound reality is emerging: the smartest thing on the planet isn't a machine—it’s a Hybrid Collective Intelligence (HI).

‍

How health policy implementation and the secondary use of health data can support preventive care, highlighting the need for a consolidated European digital health purchasing model to ensure innovation succeeds in Europe

‍

In the rapidly evolving health tech landscape, transitioning from a startup to a scaleup is a pivotal moment filled with both exhilarating opportunities and formidable challenges. This masterclass gathers seasoned founders who have successfully navigated this journey, sharing invaluable insights and lessons learned along the way. Participants will explore key strategies for scaling operations, securing funding, and building resilient teams. Real-world case studies will highlight adaptive leadership, innovation, and market positioning, providing actionable takeaways for entrepreneurs at all stages. Join us to unlock the secrets of scaling health tech ventures and to gain perspective from those who have turned ambitious visions into thriving realities.

‍

This session brings together Weight Watchers and Novo Nordisk to examine what sustainable weight loss truly requires in the era of GLP-1s. While these medications represent a major scientific breakthrough and can drive substantial weight loss, evidence increasingly shows they are not sufficient on their own to deliver lasting health outcomes.

‍

TBA

Today, all corporates leverage startups as part of their innovation processes. Many leverage innovation hubs or accelerator programs to evaluate startups and establish first pilot projects. Despite this structured process, a large percentage of follow-up engagements between corporates and startups do not lead to the desired business impact on both sides. What are the reasons and how can we improve the success rate? What are best practices for value exchange and how can we apply these to new areas like digital health or AI?

‍

Today, all corporates leverage startups as part of their innovation processes. Many leverage innovation hubs or accelerator programs to evaluate startups and establish first pilot projects. Despite this structured process, a large percentage of follow-up engagements between corporates and startups do not lead to the desired business impact on both sides. What are the reasons and how can we improve the success rate? What are best practices for value exchange and how can we apply these to new areas like digital health or AI?

‍

Stage host - Women's health session

‍

Endometriosis affects around one in ten women, yet diagnosis often takes many years, leading to pain, infertility, repeated consultations and delayed treatment. A key barrier is that high-quality transvaginal ultrasound relies on a small number of highly trained experts, which creates variability between centers, regions and individual operators.

‍

We’ve spent decades coding smarter technologies to monitor the human body - yet we’ve overlooked the operating system that runs it all: our emotions. Emotional fitness is the missing code in modern health - the capacity to regulate, process, and realign our inner states before they crash our system. In this talk, I explore how emotional intelligence and regulating skills can become the next frontier of preventive medicine - and how emotion-aware technologies and cultures could help us build humans who are not only healthier, but truly thriving.

‍

We stand at the dawn of a new biology - one that opens the black box of early human development and turns its secrets into scalable assets, redefining success in reproductive medicine and beyond.
dawn-bio's human stem-cell based platform technology illuminates a stage of life we’ve never been able to study before, offering a new foundation for breakthroughs in women’s health and preventive prenatal medicine. Its first application is an IVF solution designed to increase take home baby rate in IVF, because 20% and no improvement in 20 years is not good enough. And that is just the beginning, the platforms true potential reaches far further.
In this session, Dr. Peter Greiner shares how this new biology changes the future of human reproduction and enables bright beginnings for future generations.

‍

Trust is the foundation of every health decision - it determines whether consumers believe a product, a treatment, or a brand can truly improve their wellbeing. Yet in today’s crowded digital landscape, credible health communication is harder than ever to navigate. As the Founder & CEO of 𝐇𝐞𝐚𝐥𝐭𝐡𝐅𝐥𝐮𝐞𝐧𝐜𝐞𝐫, I will share how we are building an 𝐀𝐈-𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 𝐨𝐟 𝐭𝐫𝐮𝐬𝐭𝐞𝐝 𝐡𝐞𝐚𝐥𝐭𝐡 𝐦𝐢𝐧𝐝𝐬 to restore credibility and authenticity in the $20B+ health and wellness creator economy.

‍

Beyond the Prescription: How Digital Tools Can (and Can’t) Support Pharmacists OR The Right Digital Prescription: What Actually Helps Pharmacists — and What Doesn’t

‍

This 90-minute workshop teaches participants how to develop and market a digital therapeutic (DTx) from concept to completion. Designed for decision-makers in Digital Health, Medtech, Pharma, and startups, it covers DTx definitions, regulatory frameworks, and reimbursement pathways in Germany, including the DiGA process.

Participants will work in small groups on fictional or real DTx ideas, guided by experts through essential steps such as purpose definition, regulatory strategy, reimbursement planning, data security, and clinical evidence collection. They’ll also learn to design studies demonstrating positive healthcare effects.

The session concludes with group presentations and an open discussion on challenges encountered. Participants will leave with practical tools and resources for their projects.

‍

‍

Preparing Nurses for Accelerating Technologies: Building Digital Literacy for the Future of Care

‍

Digital health is no longer peripheral to healthcare – it’s how care gets delivered. From patient flow to decision support, the systems we build and use have become the mechanism of modern care itself. But while the pace of digital innovation in healthcare has never been faster, keeping those innovations safe, sustainable, and truly useful remains one of our biggest challenges.

‍

“Proximity Drives Belief...
…and Belief allows us to hear and internalize stories that are difficult…

Stories that help us see, that what we’ve worked on for years, still isn’t good enough.

Yet stories that can convict us to push further” ~ Joseph Isosaki

The overall HealthTech market is one of the fastest-growing sectors globally, driven by technological advancements (especially AI and digital solutions), the burden of chronic diseases, and a shift toward patient-centric and value-based care.

‍

Bringing precision health to the real world: How AI can redesign health access at scale

‍

'How to guide' - planning for digital endpoints and why they are needed

‍

Remote Care in Action: Lessons from the Nordics and Canada

‍

In an era where technology reshapes healthcare delivery, this panel brings together innovation leads from the world's most future-focused hospitals. These experts will share their insights on designing digital infrastructures that prioritize patient care while addressing societal health needs. Topics will include leveraging data analytics for personalized medicine, implementing telehealth solutions to enhance accessibility, and creating collaborative ecosystems that engage patients in their own care. Attendees will gain a deeper understanding of how to integrate cutting-edge technologies with human-centric approaches, fostering hospitals that not only heal but also enrich the communities they serve. Join us for an engaging discussion on the transformative power of digital design in healthcare.

‍

‍

‍

In the rapidly evolving health tech landscape, transitioning from a startup to a scaleup is a pivotal moment filled with both exhilarating opportunities and formidable challenges. This masterclass gathers seasoned founders who have successfully navigated this journey, sharing invaluable insights and lessons learned along the way. Participants will explore key strategies for scaling operations, securing funding, and building resilient teams. Real-world case studies will highlight adaptive leadership, innovation, and market positioning, providing actionable takeaways for entrepreneurs at all stages. Join us to unlock the secrets of scaling health tech ventures and to gain perspective from those who have turned ambitious visions into thriving realities.

‍

‍

Remote Care in Action: Lessons from the Nordics and Canada

‍

Healthcare is evolving at a pace that often exceeds the capacity of the people delivering it. New technologies, shifting priorities, and constant pressures on services create an overload that slows adoption and drains momentum.

‍

Personal and Preventative Care

‍

Traditionally, assessing a patient’s health has relied on "snapshots"—infrequent, subjective clinic visits that don't always capture the full picture of a disease. Digital biomarkers change the game. By using sensors in smartphones and wearables, we can now capture objective, continuous data from a patient’s daily life—measuring things like walking patterns in Parkinson’s or sleep quality in depression with unprecedented precision.

‍

‍

For a century, cardiovascular care has relied on invasive tests and late-stage interventions. But what if the next century could be defined by something as simple as the human voice? Subtle changes in speech can reveal early signs of heart disease weeks before hospitalization, offering a window for timely intervention.

‍

Oral dryness, or xerostomia, affects a growing share of the population—patients undergoing oncology treatments, those with autoimmune disorders, diabetes, or chronic medication use. Despite its prevalence and significant impact on quality of life, it remains an underestimated public health issue. Xerostomia not only causes local discomfort but can also impair oral flora balance, increase infection risk, and serve as an early indicator of systemic disease.

‍

How AI enabled radiology can map incidental findings that could lead to earlier diagnosis

‍

Healthcare innovation faces steep barriers: regulation, funding, and resistance. H4 observes innovators, clinicians, and patients struggling to implement new solutions. Our analysis advocates genuine alliances between innovators, clinicians, and empowered patients to understand needs. Caregivers also require early innovation training. H4 aims to transform complex innovation into accessible steps, fostering smoother adoption and greater impact through collaboration.

Cardiovascular disease remains the leading cause of death worldwide. Despite major advances in medicine and diagnostics, current approaches often detect disease too late and lack predictive precision. Exploris Health is addressing this challenge with Cardio Explorer, a novel Software as Medical Device that integrates advanced biosignal analytics and artificial intelligence to enable earlier detection, improved risk assessment, and more personalized cardiac care.

‍